The stocks were sold at $33.25 per share. The underwriters fully exercised the option to purchase an additional 1.05 million shares of common stock, resulting in a total offering of 8.05 million shares of common stock.
SCA did not sell any shares and did not receive any proceeds from the sale of the common stock. Due to the sale of shares TPG Global now owns less than 50 percent of the company’s outstanding shares of common stock. Thus, SCA is no longer a controlled company under NASDAQ listing rules.
More articles on transactions and valuation issues:
Healthcare services M&A: 10 key trends
AmSurg CFO sells 24k+ company shares
CON reform legislation introduced in South Carolina
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.